Titlebook: Oxidative Stress in Cardiovascular-Metabolic Diseases; Ali Hussein Eid,Firas Kobeissy,Ahmed F. El-Yazbi Book 2024 The Editor(s) (if applic

惡臭

Stanley Ibeh,Ismail Babale,Arthur Morah,Maha Khachab,Ali Hussein Eid,Firas Kobeissy

consent

Exaggerate

Mohammed A. El-Lakany,Abdalla M. Wedn,Mahmoud M. El-Mas

Ligament

多山

Therapeutic Strategies for Combating Reactive Oxygen Species in Cardiovascular Diseases, respiratory chain, and noncoupling NOS, along with addressing some of their inhibitors. Also, enzymatic antioxidants such as GPX4, SOD, CAT, Prx, and Trx and nonenzymatic antioxidants such as GSH and vitamins E and C are explained. In addition, potential ROS modulators are discussed in depth, inclu

災(zāi)禍

Cerebrovascular

The Impact of Reactive Oxygen Species and Matrix Metalloproteinases on Cardiometabolic Diseases,cysteine residues within the MMPs or indirectly by increasing the gene expression of MMPs. Therefore, targeting MMPs has emerged as a promising therapeutic strategy for treating cardiometabolic diseases. However, further research is needed to identify the most suitable MMP targets and to develop eff

剝削

enlist

Antioxidant Therapy in CVD: Hope or Hype,tive mechanisms. This chapter underscores the need for personalized approaches based on individual oxidative status. Mitochondrial-targeted antioxidants emerge as a promising class of therapeutic agents, specifically addressing oxidative stress within the mitochondria. This chapter details two appro

纖細(xì)